EVMNNYSEPharmaceutical Preparations

Evommune, Inc. (EVMN) earnings date, market-implied expected move, and options open interest by expiry

6.75

+0.71 · +11.73%

Regular session11:09 ET

Open6.81Volume352,201Mkt cap$218.3MP/E1.22EPS5.53

Day6.60 – 6.9840%52-wk4.94 – 33.206%

EVMN

Evommune, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

4hEvommune to webcast today at 8:30 a.m. ET on EVO570 in‑license and development plans
18hEvommune in-licenses EVO570 for $20.0 million upfront, issues $10.0 million warrants
49dEvommune (EVMN) Drops EVO756 for Eczema. Can EVO301 Carry the Pipeline?

News

Next report

Last report

+5.23%

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+12.54%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

107 managers

Top fund weight

0.01%

EVMN weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

No upcoming report date for Evommune (EVMN). No implied move.

Implied vs realized

4 reports

—≥ implied

Q3 FY25Dec 11 '25confirmed—▼−8.53%—

Q1 FY26Mar 5 '26confirmed—▲+5.62%—

May 7 '26May 7 '26confirmed±38.2%▲+1.87%×0.05

Q2 FY26Aug 6 '26confirmed—▲+5.23%—

quarterimplied−40%0+40%realized×

Q2 FY26—▲+5.23%—

May '26±38.2%▲+1.87%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 4 close

0.09OI · 3 expiries · Nov 4 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

143+104%Nov 2015d1,538+138%

121—Dec 1843d0.081,534—0.08

50+6%Feb 19106d0.13400−2%0.13

ExpiryPutsCallsP/C

Nov 2015d143+104%1,538+138%0.09

Dec 1843d121—1,534—0.08

Feb 19106d50+6%400−2%0.13

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY25

−124.75%as filednet margin

Revenue$10M—

Gross profit$10M100.00%—

Operating income−$13M−133.28%+42.04%

Pre-tax income−$12M+8.04%

Net income−$12M−124.75%+8.04%

Cost of revenue$0—

Operating expenses$23M+1.45%

Other income$853,000−90.95%

Source: SEC filings · standardized · QE Sep 30 '25 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 11:00 ET

Intraday

Event sensitivity

FOMC ×1.17· ±5.1% vs ±4.4% · 7 releases

eventrelease day|move|up · n×base

FOMCrate decision±5.1%3 of 7×1.17

NFPjobs report±4.6%6 of 10×1.05

CPIconsumer prices±3.7%1 of 10×0.85

PPIproducer prices±3.6%4 of 10×0.82

CPROFcorporate profits±2.3%5 of 7×0.53

GDPgross domestic product±1.9%5 of 10×0.44

PCEpersonal income & outlays±1.5%4 of 10×0.34

Bar = avg |move| to ±6% · tick = ±4.4% avg day · ×base = |move| ÷ ±4.4% · min 6 releases

Earnings history

EPS -0.89 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.89	—
Q1 FY26	Mar 5 '26 · confirmed	-0.64	—
Q3 FY25	Dec 11 '25 · confirmed	-8.07	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod